Abiopharma

Clinical trial NCT04195399: completion date: 2027-04-10 → 2032-12-31.

Clinical trial NCT05744921 updates: 1. completion date: 2029-02-26 → 2028-10-10 2. primary completion date: 2029-02-26 → 2028-10-10

Clinical trial NCT06074562: enrollment: 405 → 404 participants.

Clinical trial NCT07092865 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 184 → 168 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT04678856: phase: PHASE3 → PHASE2.

Clinical trial NCT07504601: start date: 2026-08-03 → 2026-08-04.

Clinical trial NCT06244082: completion date: 2027-07-31 → 2027-04-30.

Clinical trial NCT07489066: start date: 2026-06-01 → 2026-06-30.

Clinical trial NCT05765500 updates: 1. collaborators added: Sumitomo Pharma America, Inc. 2. collaborators removed: Myovant Sciences GmbH

Clinical trial NCT07223164 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-10-01 → 2025-10-31 3. primary completion date: 2026-10-01 → 2025-10-31 4. enrollment: 120 → 102 participants 5. enrollment type: ESTIMATED → ACTUAL